Search
Returning search results with filters:
Remove filter for
Last updated: 2022
Remove filter for
Type: Alert
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
- (-) 2022
- December 20222 results available
- November 20224 results available
- October 20224 results available
- September 20227 results available
- August 20228 results available
- July 20227 results available
- June 20224 results available
- May 20225 results available
- April 20225 results available
- March 20225 results available
- February 20225 results available
- January 20226 results available
Displaying 46 - 60 of 62 items.
Health Canada warns Canadians that a Vertbaudet children’s bathrobe poses a flammability hazard
AlertPublic advisory | 2022-04-05
Sodium Acetate Injection, USP - Potential for the Presence of Particulate Matter
AlertHealth professional risk communication | 2022-03-15
Ranitidine products recalled because of a nitrosamine impurity
AlertInformation update | 2022-03-11
Anticipated shortage of euthanasia products for animals
AlertHealth professional risk communication | 2022-03-10
0.9% Sodium Chloride Injection, USP and Lactated Ringer’s Injection, USP - Potential Leak During Pressure Infusion
AlertHealth professional risk communication | 2022-03-09
Pfizer recalls Inderal-LA (propranolol hydrochloride) capsules due to a nitrosamine impurity
AlertPublic advisory | 2022-03-01
Rapid antigen test kits and potential exposure to hazardous substances
AlertPublic advisory | 2022-02-24
Distribution of NUVAXOVID with English-only Vial and Carton Labels
AlertHealth professional risk communication | 2022-02-23
BEOVU (brolucizumab) – Risk of Intraocular Inflammation, Retinal Vasculitis and/or Retinal Vascular Occlusion
AlertHealth professional risk communication | 2022-02-03
Health Canada warns that products sold by Kerela Ayurvedic & Natural Herbal Consultation in Toronto, ON, may pose serious health risks
AlertPublic advisory | 2022-02-01
Lichtenberg generators pose life-threatening danger to users
AlertPublic advisory | 2022-01-19
PAXLOVID (nirmatrelvir and ritonavir) - Dosing and Dispensing in Renal Impairment, Risk of Serious Adverse Reactions Due to Drug Interactions, and English-Only Labels
AlertHealth professional risk communication | 2022-01-17
XELJANZ/XELJANZ XR (tofacitinib) – Risk of Major Adverse Cardiovascular Events, Malignancy, Thrombosis and Infection
AlertHealth professional risk communication | 2022-01-12